• Je něco špatně v tomto záznamu ?

Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price

TM. Brunt, AM. Atkinson, T. Nefau, M. Martinez, E. Lahaie, A. Malzcewski, M. Pazitny, V. Belackova, SD. Brandt,

. 2017 ; 44 (-) : 105-114. [pub] 20170501

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025048

BACKGROUND: New psychoactive substances (NPS) are on offer worldwide online, in order to shed light on the purity and price of these substances in the European Union, a research collaboration was set up involving France, United Kingdom (UK), the Netherlands, Czech Republic and Poland. METHODS: Per country, around 10 different NPS were test purchased from different webshops. Then, chemical analysis of NPS was done with according reference standards to identify and quantify the contents. RESULTS: In contrast to what is generally advertised on the webshops (>99%), purity varied considerably per test purchased NPS. Several NPS were mislabelled, some containing chemical analogues (e.g. 25B/C-NBOMe instead of 25I-NBOMe, pentedrone instead of 3,4-DMMC). But in some cases NPS differed substantially from what was advertised (e.g. pentedrone instead of AMT or 3-FMC instead of 5-MeO-DALT). Per gram, purity-adjusted prices of cathinones differed substantially between three countries of test purchase, with Poland being the least expensive. Synthetic cannabinoids were relatively the most expensive in the Czech Republic and least expensive in the UK. CONCLUSION: The current findings provides a snapshot of the price and chemical contents of NPS products purchased by different countries and in different webshops. There is a potential danger of mislabelling of NPS. The great variety in price and purity of the delivered products might be the result of the market dynamics of supply and demand and the role of law enforcement in different European countries.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025048
003      
CZ-PrNML
005      
20180718112358.0
007      
ta
008      
180709s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.drugpo.2017.03.006 $2 doi
035    __
$a (PubMed)28472731
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Brunt, Tibor Markus $u Drug Information and Monitoring System (DIMS), Netherlands Institute of Mental Health and Addiction (Trimbos Institute), Utrecht, The Netherlands. Electronic address: tbrunt@trimbos.nl.
245    10
$a Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price / $c TM. Brunt, AM. Atkinson, T. Nefau, M. Martinez, E. Lahaie, A. Malzcewski, M. Pazitny, V. Belackova, SD. Brandt,
520    9_
$a BACKGROUND: New psychoactive substances (NPS) are on offer worldwide online, in order to shed light on the purity and price of these substances in the European Union, a research collaboration was set up involving France, United Kingdom (UK), the Netherlands, Czech Republic and Poland. METHODS: Per country, around 10 different NPS were test purchased from different webshops. Then, chemical analysis of NPS was done with according reference standards to identify and quantify the contents. RESULTS: In contrast to what is generally advertised on the webshops (>99%), purity varied considerably per test purchased NPS. Several NPS were mislabelled, some containing chemical analogues (e.g. 25B/C-NBOMe instead of 25I-NBOMe, pentedrone instead of 3,4-DMMC). But in some cases NPS differed substantially from what was advertised (e.g. pentedrone instead of AMT or 3-FMC instead of 5-MeO-DALT). Per gram, purity-adjusted prices of cathinones differed substantially between three countries of test purchase, with Poland being the least expensive. Synthetic cannabinoids were relatively the most expensive in the Czech Republic and least expensive in the UK. CONCLUSION: The current findings provides a snapshot of the price and chemical contents of NPS products purchased by different countries and in different webshops. There is a potential danger of mislabelling of NPS. The great variety in price and purity of the delivered products might be the result of the market dynamics of supply and demand and the role of law enforcement in different European countries.
650    _2
$a obchod $x statistika a číselné údaje $7 D003132
650    12
$a kontaminace léku $7 D004340
650    _2
$a Evropa $7 D005060
650    _2
$a lidé $7 D006801
650    _2
$a zakázané drogy $x chemie $x ekonomika $7 D013287
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Atkinson, Amanda Marie $u Centre for Public Health, Liverpool John Moores University, Liverpool, UK.
700    1_
$a Nefau, Thomas $u Observatoire Français des Drogues et des Toxicomanies (OFDT), Paris, France.
700    1_
$a Martinez, Magali $u Observatoire Français des Drogues et des Toxicomanies (OFDT), Paris, France.
700    1_
$a Lahaie, Emmanuel $u Observatoire Français des Drogues et des Toxicomanies (OFDT), Paris, France.
700    1_
$a Malzcewski, Artur $u National Bureau for Drug Prevention, Warsaw, Poland.
700    1_
$a Pazitny, Martin $u Clinic of Addictology, Department of Psychiatry, Charles University, Prague.
700    1_
$a Belackova, Vendula $u Clinic of Addictology, Department of Psychiatry, Charles University, Prague.
700    1_
$a Brandt, Simon D $u School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
773    0_
$w MED00008614 $t The International journal on drug policy $x 1873-4758 $g Roč. 44, č. - (2017), s. 105-114
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28472731 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718112658 $b ABA008
999    __
$a ok $b bmc $g 1317179 $s 1021969
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 44 $c - $d 105-114 $e 20170501 $i 1873-4758 $m The International journal on drug policy $n Int J Drug Policy $x MED00008614
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace